The audio webcast may be accessed through the Investor Relations section of the Company's website at ir.mallinckrodt.com under Events & Presentations through this webcast link. To access the call through a conference line, participants can register here to receive a dial-in number and personalized PIN to participate in the call. Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.
ABOUT MALLINCKRODT
Mallinckrodt is dedicated to enhancing lives by providing therapeutics that strive to address unmet patient needs, and is a world-class manufacturer of high-quality generics, sterile injectables, and active pharmaceutical ingredients.
Our company consists of multiple wholly owned subsidiaries that operate in two businesses. Our Brands business is focused on autoimmune and rare diseases in areas including endocrinology, gastroenterology, hepatology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology, and urology. Our
Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission ("
Contacts
Investors
avendano.juan@endo.com
Media
huss.linda@endo.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/mallinckrodt-plc-to-report-third-quarter-2025-financial-results-on-november-10-2025-302592122.html
SOURCE